Skip to Main Content
Yale Institute for Global Health
Yale Home

INFORMATION FOR

    Diseases of the Integumentary System, Phase III

    A Phase 3 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lutikizumab in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa

    Find out more about who can participate in this trial

    Contact Information

    For more information about this study, including how to volunteer, contact Marianne Sparapani-Rusgrove

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    Create a volunteer profile

    Principal Investigator

    Sub-Investigator

    • Last Updated
      05/10/2026
    • Study IRB
      #2000037428

    Contact Information

    For more information about this study, including how to volunteer, contact Marianne Sparapani-Rusgrove